Misconceptions about Lyme Disease: Confusions Hiding behind Ill-Chosen Terminology
2002; American College of Physicians; Volume: 136; Issue: 5 Linguagem: Inglês
10.7326/0003-4819-136-5-200203050-00024
ISSN1539-3704
Autores Tópico(s)Viral Infections and Vectors
ResumoMedical Writings5 March 2002Misconceptions about Lyme Disease: Confusions Hiding behind Ill-Chosen TerminologyLeonard H. Sigal, MDLeonard H. Sigal, MDDr. Sigal: UMDNJ Robert Wood Johnson Medical School; New Brunswick, NJ 08903Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-136-5-200203050-00024 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail "The beginning of wisdom is to call things by their right names."—Ancient Chinese proverbNomenclature influences perceptions of reality and frames ensuing discussions. Imprecision contributes to misinterpretation of observations and studies, altering clinicians' approaches. The impact of imprecision and novel reinterpretation of terminology can be seen in the Lyme disease debate. A quarter century after its initial description, a review of the terminology contributing to confusion about Lyme disease is needed.Lyme disease is treatable and curable with antibiotics (1-4), especially if treated promptly, usually with an excellent long-term prognosis. The term "promptly" taken out of context suggests one must ...References1. Steere AC, Hutchinson GJ, Rahn DW, Sigal LH, Craft JE, DeSanna ET, et al . Treatment of the early manifestations of Lyme disease. Ann Intern Med. 1983;99:22-6. [PMID: 6407378] LinkGoogle Scholar2. Steere AC. Lyme disease. N Engl J Med. 1989;321:586-96. [PMID: 2668764] CrossrefMedlineGoogle Scholar3. Dattwyler RJ, Volkman DJ, Conaty SM, Platkin SP, Luft BJ. Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet. 1990;336:1404-6. [PMID: 1978873] CrossrefMedlineGoogle Scholar4. Seltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED. Long-term outcomes of persons with Lyme disease. JAMA. 2000;283:609-16. [PMID: 10665700] CrossrefMedlineGoogle Scholar5. Kalish RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC. Evaluation of study patients with Lyme disease, 10-20-year follow-up. J Infect Dis. 2001;183:453-460. [PMID: 11133377] CrossrefMedlineGoogle Scholar6. Sigal LH. Pseudo-Lyme disease. Bull Rheum Dis. 1995;44:1-3. [PMID: 8528435] MedlineGoogle Scholar7. Sigal LH. Management of Lyme disease refractory to antibiotic therapy. Rheum Dis Clin North Am. 1995;21:217-30. [PMID: 7732170] CrossrefMedlineGoogle Scholar8. Sigal LH. The Lyme disease controversy. Social and financial costs of misdiagnosis and mismanagement. Arch Intern Med. 1996;156:1493-500. [PMID: 8687256] CrossrefMedlineGoogle Scholar9. Sigal LH. Pitfalls in the diagnosis and management of Lyme disease. Arthritis Rheum. 1998;41:195-204. [PMID: 9485077] CrossrefMedlineGoogle Scholar10. Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW, et al . The early clinical manifestations of Lyme disease. Ann Intern Med. 1983;99:76-82. [PMID: 6859726] LinkGoogle Scholar11. Steere AC, Green J, Schoen RT, Taylor E, Hutchinson GJ, Rahn DW, et al . Successful parenteral penicillin therapy of established Lyme arthritis. N Engl J Med. 1985;312:869-74. [PMID: 3883177] CrossrefMedlineGoogle Scholar12. Greenberg D. New fight on Lyme disease. The New York Times. 7 July 1985, S 11LI:6. Google Scholar13. Ames L. Precaution urge on Lyme disease. The New York Times. 6 July 1986; S 11WC:1. Google Scholar14. Falvo C, Nadelman RB. Much must be learned about Lyme diseae [Letter]. The New York Times. 26 September 1987; S 1:26. Google Scholar15. Kirkland KB, Klimko TB, Meriwether RA, Schriefer M, Levin M, Levine J, et al . Erythema migrans-like rash illness at a camp in North Carolina: a new tick-borne disease? Arch Intern Med. 1997;157:2635-41. [PMID: 9531233] CrossrefMedlineGoogle Scholar16. Barbour AG, Maupin GO, Teltow GJ, Carter CJ, Piesman J. Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness. J Infect Dis. 1996;173:403-9. [PMID: 8568302] CrossrefMedlineGoogle Scholar17. Halperin JJ. Neuroborreliosis. Am J Med. 1995; 98:52S-56S; discussion 56S-59S. [PMID: 7726192] Google Scholar18. Barbour AG, Fish D. The biological and social phenomenon of Lyme disease. Science. 1993;260:1610-6. [PMID: 8503006] CrossrefMedlineGoogle Scholar19. Pachner AR. Borrelia burgdorferi in the nervous system: the new "great imitator". Ann N Y Acad Sci. 1988;539:56-64. [PMID: 3190104] CrossrefMedlineGoogle Scholar20. Sigal LH. Lyme disease: testing and treatment. Who should be tested and treated for Lyme disease and how? Rheum Dis Clin North Am. 1993;19:79-93. [PMID: 8356262] CrossrefMedlineGoogle Scholar21. Sigal LH. Early disseminated Lyme disease: cardiac manifestations. Am J Med. 1995; 98:25S-28S; discussion 28S-29S. [PMID: 7726189] Google Scholar22. Sigal LH. A symposium: national clinical conference on Lyme disease. Am J Med. 1995;98:1S-90S. CrossrefGoogle Scholar23. Nadelman RB, Wormser GP. Erythema migrans and early Lyme disease. Am J Med. 1995; 98:15S-23S; discussion 23S-24S. [PMID: 7726187] Google Scholar24. Steere AC. Musculoskeletal manifestations of Lyme disease. Am J Med. 1995; 98:44S-48S; discussion 48S-51S. [PMID: 7726191] Google Scholar25. Pachner AR. Early disseminated Lyme disease: Lyme meningitis. Am J Med. 1995; 98:30S-37S; discussion 37S-43S. [PMID: 7726190] Google Scholar26. Ilowite NT. Muscle, reticuloendothelial, and late skin manifestations of Lyme disease. Am J Med. 1995;98:63S-68S. [PMID: 7726194] CrossrefMedlineGoogle Scholar27. Sigal LH. Lyme disease: a review of aspects of its immunology and immunopathogenesis. Annu Rev Immunol. 1997;15:63-92. [PMID: 9143682] CrossrefMedlineGoogle Scholar28. Gaudino EA, Coyle PK, Krupp LB. Post-Lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences. Arch Neurol. 1997;54:1372-6. [PMID: 9362985] CrossrefMedlineGoogle Scholar29. Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep. 1990;39:1-43. [PMID: 2122225] MedlineGoogle Scholar30. . Sigal L, , eds. Lyme Disease in New Jersey: A Practical Guide for Clinicians. Lawrenceville, NJ: Academy of Medicine of New Jersey; 1993:127. Google Scholar31. . Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995;44:590-1. [PMID: 7623762] MedlineGoogle Scholar32. Hilton E, Tramontano A, DeVoti J, Sood SK. Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. J Clin Microbiol. 1997;35:774-6. [PMID: 9041433] CrossrefMedlineGoogle Scholar33. Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, Wormser GP. Serodiagnosis in early Lyme disease. J Clin Microbiol. 1993;31:3090-5. [PMID: 8308100] CrossrefMedlineGoogle Scholar34. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34:1-9. [PMID: 8748261] CrossrefMedlineGoogle Scholar35. Sigal LH. Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med. 1990;88:577-81. [PMID: 2346158] CrossrefMedlineGoogle Scholar36. Sigal LH. Persisting complaints attributed to chronic Lyme disease: possible mechanisms and implications for management. Am J Med. 1994;96:365-74. [PMID: 8166157] CrossrefMedlineGoogle Scholar37. Girschick HJ, Huppertz HI, Rüssmann H, Krenn V, Karch H. Intracellular persistence of Borrelia burgdorferi in human synovial cells. Rheumatol Int. 1996;16:125-32. [PMID: 8893378] CrossrefMedlineGoogle Scholar38. Ma Y, Sturrock A, Weis JJ. Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect Immun. 1991;59:671-8. [PMID: 1987083] CrossrefMedlineGoogle Scholar39. Klempner MS, Noring R, Rogers RA. Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi . J Infect Dis. 1993;167:1074-81. [PMID: 8486939] CrossrefMedlineGoogle Scholar40. Georgilis K, Peacocke M, Klempner MS. Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro. J Infect Dis. 1992;166:440-4. [PMID: 1634816] CrossrefMedlineGoogle Scholar41. Brouqui P, Badiaga S, Raoult D. Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin. Antimicrob Agents Chemother. 1996;40:1552-4. [PMID: 8726038] CrossrefMedlineGoogle Scholar42. Sigal LH. Antibiotics for the treatment of rheumatologic syndromes. Rheum Dis Clin North Am. 1999;25:861-81, viii. [PMID: 10573763] CrossrefMedlineGoogle Scholar43. Sigal LH. Illness behavior and the biomedical model. Bull Rheum Dis. 1997;46:1-4. [PMID: 9046121] MedlineGoogle Scholar44. Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, et al . Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345:85-92. [PMID: 11450676] CrossrefMedlineGoogle Scholar45. Hsu VM, Patella SJ, Sigal LH. "Chronic Lyme disease" as the incorrect diagnosis in patients with fibromyalgia. Arthritis Rheum. 1993;36:1493-500. [PMID: 8240427] CrossrefMedlineGoogle Scholar46. Sigal LH, Patella SJ. Lyme arthritis as the incorrect diagnosis in pediatric and adolescent fibromyalgia. Pediatrics. 1992;90:523-8. [PMID: 1408503] MedlineGoogle Scholar47. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA. 1993;269:1812-6. [PMID: 8459513] CrossrefMedlineGoogle Scholar48. Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med. 1998;128:354-62. [PMID: 9490595] LinkGoogle Scholar49. Ettestad PJ, Campbell GL, Welbel SF, Genese CA, Spitalny KC, Marchetti CM, et al . Biliary complications in the treatment of unsubstantiated Lyme disease. J Infect Dis. 1995;171:356-61. [PMID: 7844372] CrossrefMedlineGoogle Scholar50. Sigal LH. Lyme disease: primum non nocere [Editorial]. J Infect Dis. 1995;171:423-4. [PMID: 7844380] CrossrefMedlineGoogle Scholar51. Patel R, Grogg KL, Edwards WD, Wright AJ, Schwenk NM. Death from inappropriate therapy for Lyme disease. Clin Infect Dis. 2000;31:1107-9. [PMID: 11049799] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Leonard H. Sigal, MDAffiliations: Dr. Sigal: UMDNJ Robert Wood Johnson Medical School; New Brunswick, NJ 08903Acknowledgments: The author thanks all of the patients seen at The Lyme Disease Center for helping to teach us about Lyme disease and that which has been misdiagnosed as Lyme disease; the housestaff and rheumatology fellows of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, who have been of such great assistance in the care of these patients; the Clinic staff for their service to the patients; and the Division of Rheumatology staff for making all of this care and work possible.Grant Support: By the Morris L. Sigal Medical Research Foundation; Arthritis Foundation, New Jersey Chapter; and the University of Medicine and Dentistry of New Jersey Foundation.Corresponding Author: Leonard H. Sigal, MD, 1 Robert Wood Johnson Place, MEB 484, New Brunswick, NJ 08903-0019. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoLyme Disease Controversy: Use and Misuse of Language Andrew Lautin Lyme Disease Controversy: Use and Misuse of Language Edward L. McNeil Lyme Disease Controversy: Use and Misuse of Language Kenneth B. Liegner Lyme Disease Controversy: Use and Misuse of Language Raphael B. Stricker Lyme Disease Controversy: Use and Misuse of Language Leonard H. Sigal Metrics Cited byThe year that shaped the outcome of the OspA vaccine for human Lyme disease"Because the country, it seems though, has turned their back on me": Experiences of institutional betrayal among veterans living with Gulf War IllnessExperience of Lyme disease and preferences for precautions: a cross-sectional survey of UK patientsExploring gaps in our knowledge on Lyme borreliosis spirochaetes – Updates on complex heterogeneity, ecology, and pathogenicityAlternative Conceptions of Plate Tectonics Held by Nonscience UndergraduatesNeuroborreliosis in the South West of EnglandEnquête étiologique standardisée sur une cohorte de 30 patients atteints de troubles neurologiques et cognitifs chroniques après piqûre de tiquesPerspectives on "Chronic Lyme Disease"Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical studyCertains symptômes cliniques aspécifiques ont-ils une origine borrélienne?Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritisChoosing the Right Antibiotic in Ambulatory CareThe Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of AmericaACVIM Small Animal Consensus Statement on Lyme Disease in Dogs: Diagnosis, Treatment, and PreventionCommentary: 'What's in a name? That which we call a rose by any other name would smell as sweet.' Shakespeare W. Romeo and Juliet, II, ii(47–48)Lyme borreliosisLyme DiseaseProgress and controversy surrounding vaccines against Lyme diseaseCanine borreliosisLyme Disease Controversy: Use and Misuse of LanguageAndrew Lautin, MDLyme Disease Controversy: Use and Misuse of LanguageEdward L. McNeil, MDLyme Disease Controversy: Use and Misuse of LanguageKenneth B. Liegner, MDLyme Disease Controversy: Use and Misuse of LanguageRaphael B. Stricker, MDVaccination for lyme disease: Cost-effectiveness versus cost and value 5 March 2002Volume 136, Issue 5Page: 413-419KeywordsAntibioticsAntibodiesArthritisFatigueFearInfectious diseasesLyme diseasePatientsSerologySyphilis ePublished: 5 March 2002 Issue Published: 5 March 2002 Copyright & PermissionsCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Referência(s)